FILANA THERAPEUTICS, INC. - Common Stock (FLNA)

CUSIP: 14817C107

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 7 signals
Share change
+695,637
Put/Call ratio
99%
SEC-reported price per share
$24.12
Number of holders
140
Value change
+$15,058,161
Number of buys
73
Open additional details 1 more signal available
Number of sells
47
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
48,331,225

Security key

14817C107

Report period

Q1 2023

Institutions

140

Top holders

10

Ownership snapshot

Top reported holders of FLNA - FILANA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
31 Dec 2022
13F Highest disclosed value: $75,756,156 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $75.76M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $75.76M
VANGUARD GROUP INC $64.9M
STATE STREET CORP $29.36M
GEODE CAPITAL MANAGEMENT, LLC $20.94M
Gallacher Capital Management LLC $17.39M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$75,756,156
2,564,528 shares
— 31 Dec 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$64,897,164
2,196,925 shares
— 31 Dec 2022
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$29,364,119
994,046 shares
— 31 Dec 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$20,937,000
708,792 shares
— 31 Dec 2022
Gallacher Capital Management LLC
13F
Company
13F
—
denominator unverified
$17,385,264
588,533 shares
— 31 Dec 2022
Invesco Ltd.
13F
Company
13F
—
denominator unverified
$12,415,367
420,290 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
140
Shares
11,914,630
Rows available
140
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders
140
Q1 2023 holders
140
Holder diff
0
Investor Q1 2023 Shares Q1 2023 Shares Share Diff Share Chg % Q1 2023 value Q1 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .